MX352906B - Fragmentos de la subunidad pa de rna polimerasa dependiente de rna del virus pandemico h1n1 2009 de influenza a y su uso. - Google Patents
Fragmentos de la subunidad pa de rna polimerasa dependiente de rna del virus pandemico h1n1 2009 de influenza a y su uso.Info
- Publication number
- MX352906B MX352906B MX2012010652A MX2012010652A MX352906B MX 352906 B MX352906 B MX 352906B MX 2012010652 A MX2012010652 A MX 2012010652A MX 2012010652 A MX2012010652 A MX 2012010652A MX 352906 B MX352906 B MX 352906B
- Authority
- MX
- Mexico
- Prior art keywords
- subunit
- compounds
- polypeptide
- relates
- polypeptide fragments
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 8
- 241001500351 Influenzavirus A Species 0.000 title 1
- 108060004795 Methyltransferase Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 5
- 102000004533 Endonucleases Human genes 0.000 abstract 3
- 108010042407 Endonucleases Proteins 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 208000036142 Viral infection Diseases 0.000 abstract 2
- 208000037797 influenza A Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 1
- 241000712464 Orthomyxoviridae Species 0.000 abstract 1
- 241000150350 Peribunyaviridae Species 0.000 abstract 1
- 108020000999 Viral RNA Proteins 0.000 abstract 1
- 238000000205 computational method Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002616 endonucleolytic effect Effects 0.000 abstract 1
- 238000002424 x-ray crystallography Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34033510P | 2010-03-16 | 2010-03-16 | |
PCT/EP2011/001274 WO2011113579A2 (fr) | 2010-03-16 | 2011-03-15 | Fragments polypeptidiques du virus h1n1 pandémique de la grippe a de 2009 qui présentent une activité endonucléasique et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012010652A MX2012010652A (es) | 2013-02-07 |
MX352906B true MX352906B (es) | 2017-12-13 |
Family
ID=43983275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012010652A MX352906B (es) | 2010-03-16 | 2011-03-15 | Fragmentos de la subunidad pa de rna polimerasa dependiente de rna del virus pandemico h1n1 2009 de influenza a y su uso. |
Country Status (12)
Country | Link |
---|---|
US (3) | US9181307B2 (fr) |
EP (1) | EP2547696B1 (fr) |
JP (2) | JP2013521786A (fr) |
KR (1) | KR20130075726A (fr) |
CN (2) | CN105273066A (fr) |
AU (1) | AU2011229469B2 (fr) |
BR (1) | BR112012023166A2 (fr) |
CA (1) | CA2790183A1 (fr) |
IL (1) | IL260192A (fr) |
MX (1) | MX352906B (fr) |
SG (3) | SG183375A1 (fr) |
WO (1) | WO2011113579A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG183375A1 (en) * | 2010-03-16 | 2012-09-27 | European Molecular Biology Lab Embl | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
US8859290B2 (en) * | 2011-07-22 | 2014-10-14 | Rutgers, The State University Of New Jersey | Inhibitors of influenza endonuclease activity and tools for their discovery |
JP6918305B2 (ja) * | 2017-03-10 | 2021-08-11 | 地方独立行政法人神奈川県立産業技術総合研究所 | インフルエンザウイルスの増殖を阻害するモノクローナル抗体 |
CN112837764B (zh) * | 2021-01-21 | 2023-07-07 | 北京晶泰科技有限公司 | 分子杂交方法及平台 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2340475T3 (es) * | 2002-05-01 | 2010-06-04 | Vertex Pharmaceuticals Incorporated | Estructura cristalizada de proteina aurora-2 y sus bolsillos de union. |
EP2197901B1 (fr) * | 2007-10-09 | 2013-12-11 | European Molecular Biology Laboratory (Embl) | Fragments solubles de poches de liaison à la coiffe de l'arn et leur utilisation |
CN101514335B (zh) * | 2008-02-22 | 2013-04-17 | 中国科学院生物物理研究所 | 流感病毒聚合酶亚基pa的表达纯化及pa氨基端及pa羧基端与pb1氨基端多肽复合体的晶体结构 |
SG183375A1 (en) | 2010-03-16 | 2012-09-27 | European Molecular Biology Lab Embl | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
-
2011
- 2011-03-15 SG SG2012061081A patent/SG183375A1/en unknown
- 2011-03-15 SG SG10201601365RA patent/SG10201601365RA/en unknown
- 2011-03-15 US US13/635,064 patent/US9181307B2/en not_active Expired - Fee Related
- 2011-03-15 SG SG10201703245SA patent/SG10201703245SA/en unknown
- 2011-03-15 EP EP11709643.8A patent/EP2547696B1/fr not_active Not-in-force
- 2011-03-15 CN CN201510595018.5A patent/CN105273066A/zh active Pending
- 2011-03-15 BR BR112012023166-9A patent/BR112012023166A2/pt not_active IP Right Cessation
- 2011-03-15 CN CN201180014380.9A patent/CN102803288B/zh not_active Expired - Fee Related
- 2011-03-15 MX MX2012010652A patent/MX352906B/es active IP Right Grant
- 2011-03-15 KR KR1020127026664A patent/KR20130075726A/ko active Search and Examination
- 2011-03-15 JP JP2012557443A patent/JP2013521786A/ja not_active Withdrawn
- 2011-03-15 WO PCT/EP2011/001274 patent/WO2011113579A2/fr active Application Filing
- 2011-03-15 CA CA2790183A patent/CA2790183A1/fr active Pending
- 2011-03-15 AU AU2011229469A patent/AU2011229469B2/en not_active Ceased
-
2015
- 2015-06-26 US US14/751,634 patent/US9783794B2/en not_active Expired - Fee Related
-
2016
- 2016-03-17 JP JP2016053802A patent/JP2016189772A/ja active Pending
-
2017
- 2017-08-08 US US15/672,091 patent/US20180044649A1/en not_active Abandoned
-
2018
- 2018-06-21 IL IL260192A patent/IL260192A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US9181307B2 (en) | 2015-11-10 |
SG10201703245SA (en) | 2017-05-30 |
CN102803288B (zh) | 2015-09-23 |
CN105273066A (zh) | 2016-01-27 |
US9783794B2 (en) | 2017-10-10 |
KR20130075726A (ko) | 2013-07-05 |
US20130023565A1 (en) | 2013-01-24 |
JP2013521786A (ja) | 2013-06-13 |
IL260192A (en) | 2018-07-31 |
US20160053241A1 (en) | 2016-02-25 |
SG183375A1 (en) | 2012-09-27 |
JP2016189772A (ja) | 2016-11-10 |
CN102803288A (zh) | 2012-11-28 |
SG10201601365RA (en) | 2016-03-30 |
WO2011113579A3 (fr) | 2012-08-02 |
MX2012010652A (es) | 2013-02-07 |
BR112012023166A2 (pt) | 2020-08-25 |
WO2011113579A2 (fr) | 2011-09-22 |
EP2547696A2 (fr) | 2013-01-23 |
US20180044649A1 (en) | 2018-02-15 |
AU2011229469B2 (en) | 2015-01-22 |
EP2547696B1 (fr) | 2018-05-23 |
CA2790183A1 (fr) | 2011-09-22 |
AU2011229469A1 (en) | 2012-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021007679A (es) | Anticuerpos humanos para hemaglutinina de influenza. | |
EA201490654A1 (ru) | Новые ингибиторы вирусной репликации | |
EA029939B8 (ru) | Человеческие связывающие молекулы, обладающие способностью нейтрализовывать вирус гриппа h3n2, и их применение | |
BR112015022790A8 (pt) | molécula biespecífica, composição farmacêutica, método de tratamento de uma infecção por vírus latente em um indivíduo em necessidade de tal tratamento, método de tratamento de uma infecção por vírus persistente em um indivíduo em necessidade de tal tratamento, método de tratamento de uma infecção por vírus inativo em um indivíduo em necessidade de tal tratamento, método para exterminar uma célula que contém um genoma viral, e, método para exterminar uma célula que expressa uma proteína viral | |
EP3816288A3 (fr) | Modulation de l'expression du virus de l'hépatite b (vhb) | |
Sakabe et al. | A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection | |
GB0921730D0 (en) | Method of treatment | |
PH12015502230A1 (en) | Novel viral replication inhibitors | |
WO2010069600A8 (fr) | Fragments de polypeptide possédant une activité d'endonucléase et leur utilisation | |
BR112017024481A2 (pt) | inibidores de ebna1 e métodos de uso dos mesmos | |
NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
MX352906B (es) | Fragmentos de la subunidad pa de rna polimerasa dependiente de rna del virus pandemico h1n1 2009 de influenza a y su uso. | |
EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
MX2014012285A (es) | Composicion farmaceutica que contiene un inhibidor de serina proteasa para tratar o prevenir infeccion por el virus de la influenza. | |
BR112015010196A2 (pt) | métodos de tratar doença do fígado | |
Su et al. | Emergence and pandemic potential of avian influenza a (H7N9) virus | |
MX349530B (es) | Metodos para producir particulas de virus con glucosilacion simplificada de proteinas de superficie. | |
Masoodi et al. | Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic | |
EA201792482A1 (ru) | Соединения-пептидомиметики, нейтрализующие вирус гриппа | |
WO2018056528A3 (fr) | Vaccin contre la grippe b | |
Manohar | In silico analysis of compounds from Stemona tuberosa as an inhibitor for N1 neuraminidase of H5N1 avian virus | |
MX2019011324A (es) | Bloqueo de cxcr4/cxcr7 y tratamiento de enfermedad asociada con el virus del papiloma humano. | |
Mebratu et al. | Bcl-2 Interacting Killer (BIK) Augments Influenza A Virus Replication and Severity of Flu | |
del Campo | La nueva gripe A/H1N1 o gripe A/H1N1 (2009) | |
EA201370057A1 (ru) | Средство против вируса гриппа b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |